Please assess the completion status of the following clinical trial:

Trial Title: User Testing of the Evivo Screening Test

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Infants aged 0-6 months.~* Generally healthy infants.~Exclusion Criteria:~* Infants should not have an acute infection.~* Not intended for use with stool containing meconium.~* Infants with jaundice should not be tested until it has resolved.~* This test should not be used for infants with carbohydrate malabsorption syndrome, which may present with one or more of the following persistent signs: abnormally foul-smelling, mucus-containing, and/or green frothy stools.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 6 Months
- Healthy Volunteers: t

Study Arms:
- Infants less than 6 months of age (Type: OTHER): The Evivo Infant Gut Bifidobacterium Screening Test study is a single-group interventional study of 600 female and male infants who are less than 6 months of age and generally healthy.

Based on this trial design, predict the completion outcome and termination type (if applicable).